Salivary neutralizing activity against herpes simplex virus type 1.

Area of Science:

• Virology
• Immunology
• Oral Health

Background:

• Herpes simplex virus type 1 (HSV-1) is a common cause of oral infections.
• Understanding the immune response in saliva is crucial for managing HSV-1.
• Previous clinical history of HSV-1 infection was noted in 16 out of 40 patients.

Purpose of the Study:

• To investigate the presence and nature of neutralizing activity against HSV-1 in human saliva.
• To identify the specific immunoglobulin class responsible for HSV-1 neutralization in saliva and serum.

Main Methods:

• Saliva samples from 40 patients were collected, concentrated, and sterilized.
• Neutralizing activity was quantified using a plaque-reduction assay.
• Antisera to human immunoglobulin were used to determine the class of neutralizing antibodies.

Main Results:

• Salivary neutralizing activity against HSV-1 was detected in 62% of patients with a history of oral lesions.
• The IgG class of immunoglobulin was identified as a significant HSV-1-neutralizing component.
• This neutralizing activity was observed in both saliva and serum samples.

Conclusions:

• Human saliva possesses significant neutralizing activity against HSV-1, particularly in individuals with a history of infection.
• Immunoglobulin G is a key factor in the humoral immune response to HSV-1 in both oral and systemic compartments.
• These findings highlight the role of salivary immunity in controlling HSV-1 infections.